Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments 中文版
21 Jul, 2025 (Monday)

            
BEIGENE(6160)
Analysis:
BeOne Medicines will announce its second-quarter results for this year on August 6. Its first quarter delivered another strong performance, with total revenue reaching $1.1 billion, a 49% year-on-year increase, primarily driven by sales growth of Brukinsa (zanubrutinib) in the U.S. and Europe. Brukinsa is now approved in 75 markets globally, with new inclusions or expanded reimbursement in 11 markets during the first quarter, including Japan, Europe, and Brazil. Its global sales reached $792 million, up 62% year-on-year. The U.S. remains the group’s largest market, with product revenue of $563 million, a 60.4% year-on-year increase, where over 60% of the quarter-on-quarter growth came from expanded use in chronic lymphocytic leukemia (CLL). Brukinsa leads in the treatment of CLL and all other approved indications in the U.S., with its market share continuing to grow. In Europe, Brukinsa’s first-quarter sales reached $116 million, up 73%, driven by market share gains in major European markets, including Germany, Italy, Spain, France, and the United Kingdom. Another product, Tislelizumab, is approved in 46 markets globally, with reimbursement added in 11 markets in the first quarter, including the U.S., Europe, and China. Its first-quarter sales were $171 million, up 18%. Additionally, products licensed from Amgen contributed to product revenue growth. In the first quarter, the group achieved profitability under U.S. Generally Accepted Accounting Principles (GAAP), with significantly improved operating cash flow. GAAP net profit was $1.27 million, a substantial improvement from a $251 million loss in the same period last year, driven by revenue growth and improved operating leverage. Adjusted net profit was $136 million, compared to an adjusted net loss of $145 million in the prior year. The first-quarter GAAP gross margin was 85.1%, up 1.8 percentage points from the previous year, primarily due to Brukinsa’s higher share of global sales compared to other products in the portfolio. Gross margin also benefited from improved production efficiency for Brukinsa and Tislelizumab. The group maintains its full-year 2025 revenue and expense guidance, projecting total revenue of $4.9 billion to $5.3 billion, with gross margin expected to range between 80% and 90%. BeiGene will host an Investor R&D Day on June 26 to highlight its developing breast cancer pipeline and broader solid tumor treatment portfolio. With a diversified global business spanning six continents, the adoption of the new English name BeOne Medicines, and the relocation of its registration to Switzerland, the group is advancing toward becoming one of the world’s most influential oncology innovation companies. (I do not hold the aforementioned stock.)
Strategy:
Buy-in Price: $176.00, Target Price: $194.00, Cut Loss Price: $165.00


MOBVISTA(1860)
Analysis:
Wei Wei, Director of the Science and Technology Department of the Ministry of Industry and Information Technology, stated in his speech at the "2025 High-Level Symposium on AI Hardware-Software Collaborative Innovation and the 15th Plenary Session of the China AI Industry Alliance" that the Beijing Economic-Technological Development Area is fully committed to building a citywide AI ecosystem. This effort includes establishing the nation’s first AI data training base and the city’s largest public computing power platform, introducing the "AI 20" and "Data 20" policy measures, and launching a special industrial fund exceeding 1 billion yuan to support major projects in foundational chips, servers, software frameworks, industry models, and data governance. The company is a globally leading mobile advertising and marketing technology platform dedicated to providing all-in-one growth solutions for developers and marketers worldwide. Its comprehensive services—including user acquisition, traffic monetization, analytics, creative automation, and intelligent media buying—aim to help clients enhance advertising ROI and overcome bottlenecks in app growth.
Strategy:
Buy-in Price: $9.06, Target Price: $10.00, Cut Loss Price: $8.20



Kuaishou (1024.HK) - AI-driven end-to-end efficiency improvement

Financial summary

Kuaishou is a leading content community and social platform in China and globally. As a technology company powered by and built upon artificial intelligence, Kuaishou is dedicated to continuously enriching its services and application scenarios through ongoing technological innovation and product upgrades, thereby creating value for its customers. On Kuaishou, users record and share their lives through short videos and live streaming, discover what they need, and showcase their talents. By closely collaborating with content creators and businesses, Kuaishou provides technologies, products, and services that meet users' diverse needs, including entertainment, online marketing services, e-commerce, local lifestyle services, gaming, and more.

Financial performance

In the first quarter of 2025, the company achieved total revenue of RMB 32.6 billion (Chinese yuan, same below), representing a year-over-year increase of 10.9%. In terms of profitability, operating profit reached RMB 4.3 billion, up 6.6% YoY, while adjusted net profit was RMB 4.6 billion, a 4.4% YoY increase. By segment, 1Q25 online marketing services revenue grew 8.0% YoY to RMB 18.0 billion, primarily driven by increased ad spending from marketing clients due to the adoption of AI-powered ad placement solutions. Live streaming revenue rose 14.4% YoY to RMB 9.8 billion, attributed to refined operations and diversified content. Other services revenue increased 15.2% YoY to RMB 4.8 billion, mainly fueled by e-commerce business growth.

In terms of expenses, the company’s sales and marketing expenses as a percentage of total revenue decreased to 30.4% in Q1 2025 from 31.9% in the same period last year, primarily due to improved operational efficiency.

In Q1 2025, Kuaishou’s average daily active users (DAUs) and monthly active users (MAUs) reached 408 million and 712 million, respectively, up 3.6% and 2.1% YoY. The app’s DAUs hit a record high and surpassed 400 million for the third consecutive quarter. Through refined user growth strategies, the average customer acquisition cost (CAC) for new users decreased. Meanwhile, enhanced content consumption experiences—driven by high-quality content, iterative traffic distribution mechanisms, and diverse community engagement features—further improved new user retention rates.

Online Marketing Services: External-loop business as the core growth engine, AI-driven end-to-end efficiency improvement

In the first quarter of 2025, external-loop marketing services served as the primary growth driver, with AI technology deeply enhancing end-to-end operational efficiency. Within the content consumption sector, marketing expenditure for short dramas achieved rapid year-over-year growth. Marketing clients leveraged native pathways to elevate content value and strengthen user engagement, deepening the platform’s understanding of user preferences. In the local lifestyle sector, solutions such as native direct messaging and lead form collection boosted conversion rates, driving marketing expenditure growth of over 50.0% YoY.

Meanwhile, AI technology empowered the entire workflow of online marketing service solutions, delivering efficient brand marketing and performance-driven conversions. According to management, Q2 online marketing service revenue is expected to return to double-digit YoY growth, with accelerated ad expenditure growth in the generalized shelf-based advertising space.

E-commerce: Tripartite Operating Model Drives Continuous Optimization Across Multiple Domains

The company continued to enhance consumers' shopping experience. In Q1 2025, e-commerce GMV grew by 15.4% YoY to RMB 332.3 billion, while the monthly active buyer count reached 135 million, up 7.1% YoY. By continuously developing growth resources and widely applying large-scale models, the company provided merchants with a full suite of AI-powered livestreaming tools, leading to a YoY increase of over 30.0% in new merchants joining Kuaishou during Q1 2025. Through the establishment of a tripartite operating model integrating "livestreaming + mall + short videos," the company drove continuous optimization across multiple domains. In Q1 2025, generalized shelf-based e-commerce contributed approximately 30.0% of total GMV, with the number of daily active merchants growing over 40.0% YoY, while short video-based e-commerce GMV surged by over 40.0% YoY.

Livestreaming: YoY Growth Returns to Positive Territory

The company further refined its operations in key categories such as multi-host livestreaming and group livestreaming. By the end of Q1 2025, the number of signed agencies increased by over 25.0% YoY, while the number of signed streamers grew by over 40.0% YoY.

Company valuation

In April 2025, the company launched Keling AI 2.0, introducing the innovative concept of multimodal vision-language and rolling out multimodal editing features, which have now been widely adopted across various industries including advertising marketing, short dramas, and smart devices. Leveraging AI technology, the company has empowered the entire process of online marketing service solutions, encompassing AIGC marketing material production, intelligent marketing placement agents, and large-scale marketing acompañrecommendation models, thereby enhancing clients' marketing conversion efficiency. In Q1 2025, the daily average ad spending on AIGC marketing materials reached approximately RMB 30 million.

Overall, we are optimistic about the company's medium-to-long-term growth prospects and believe its fair valuation should be 17 times the projected 2025 PE, corresponding to a target price of HK$73 per share. We forecast the company's 2025-2027 operating revenues at RMB 142.4/156.2/170.7 billion, with net profits of RMB 16.8/21.3/26.3 billion, translating to EPS of RMB 3.91/4.94/6.11. The current share price implies PE multiples of 15/12/10x for 2025-2027. In conclusion, we initiate coverage with an "Accumulate" rating.

Risk factors

1) Slower-than-exhibitspected progress in AI applications;
2) User growth slowdown;
3) Regulatory risks in the internet industry.

Financials

"財務資料"

Current Price as of: Jul 14 2025
Exchange rate: HKD/RMB = 0.91
Source: PSHK Est.

Download PDF version...




Recommendation on 21-7-2025
RecommendationAccumulate
Price on Recommendation Date$ 65.000
Suggested purchase priceN/A
Target Price$ 73.000
Writer Info
Megan Tao
(Research Analyst)
Tel: +852 2277 6515
Email:
megantao@phillip.com.hk

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

版權所有, 翻印必究。

Copyright(C) 2025 Phillip Securities (HK) Ltd. All Rights Reserved.